Research Portal

Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study

Research output: Contribution to journal › Article › peer-review

Standard Standard

Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study. / Brooks, D.; Sagar, H.; Hindle, J.V.
In: Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 74, No. 8, 01.08.2003, p. 1071-1079.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Brooks, D, Sagar, H & Hindle, JV 2003, 'Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study', Journal of Neurology, Neurosurgery, and Psychiatry, vol. 74, no. 8, pp. 1071-1079. https://doi.org/10.1136/jnnp.74.8.1071

APA

Brooks, D., Sagar, H., & Hindle, J. V. (2003). Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study. Journal of Neurology, Neurosurgery, and Psychiatry, 74(8), 1071-1079. https://doi.org/10.1136/jnnp.74.8.1071

CBE

Brooks D, Sagar H, Hindle JV. 2003. Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study. Journal of Neurology, Neurosurgery, and Psychiatry. 74(8):1071-1079. https://doi.org/10.1136/jnnp.74.8.1071

MLA

Brooks, D., H. Sagar and J.V. Hindle. "Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study". Journal of Neurology, Neurosurgery, and Psychiatry. 2003, 74(8). 1071-1079. https://doi.org/10.1136/jnnp.74.8.1071

VancouverVancouver

Brooks D, Sagar H, Hindle JV. Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study. Journal of Neurology, Neurosurgery, and Psychiatry. 2003 Aug 1;74(8):1071-1079. doi: 10.1136/jnnp.74.8.1071

Author

Brooks, D. ; Sagar, H. ; Hindle, J.V. / Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study. In: Journal of Neurology, Neurosurgery, and Psychiatry. 2003 ; Vol. 74, No. 8. pp. 1071-1079.

RIS

TY - JOUR

T1 - Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study

AU - Brooks, D.

AU - Sagar, H.

AU - Hindle, J.V.

PY - 2003/8/1

Y1 - 2003/8/1

U2 - 10.1136/jnnp.74.8.1071

DO - 10.1136/jnnp.74.8.1071

M3 - Article

VL - 74

SP - 1071

EP - 1079

JO - Journal of Neurology, Neurosurgery, and Psychiatry

JF - Journal of Neurology, Neurosurgery, and Psychiatry

SN - 0022-3050

IS - 8

ER -